Critical Issues in Lung Transplantation

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Errol Bush, MD
Disclosure: Johnson & Johnson Ethicon: Advisory Board (Terminated)

Stephanie Chang, MD
Disclosure: Astra Zeneca: Advisory Board (Ongoing); AtriCure,: Consultant (Ongoing); Lung Bioengineering: Advisory Board (Ongoing)

Presentations

  1. Is Transplantation with COVID-19 Positive Donor Lungs Safe? A US Nationwide Analysis
    Richa Asija, DO MS
     
  2. Cost effectiveness of ex vivo lung perfusion for lung transplant recipients in the United States
    Johnathan Kent, MD
     
  3. Update on Prolonged organ storage: What temperature, how long, what time of day?
    Shaf Keshavjee, MD MSc FRCSC FACS
    Disclosure: Abbott: Advisory Board (Ongoing), Consultant (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); SQI Diagnostics: Consultant (Ongoing); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  4. Panel Discussion
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
02/01/2023
Activity expires: 
02/01/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Errol Bush, MD
Disclosure: Johnson & Johnson Ethicon: Advisory Board (Terminated)

Stephanie Chang, MD
Disclosure: Astra Zeneca: Advisory Board (Ongoing); AtriCure,: Consultant (Ongoing); Lung Bioengineering: Advisory Board (Ongoing)

Presentations

  1. Is Transplantation with COVID-19 Positive Donor Lungs Safe? A US Nationwide Analysis
    Richa Asija, DO MS
     
  2. Cost effectiveness of ex vivo lung perfusion for lung transplant recipients in the United States
    Johnathan Kent, MD
     
  3. Update on Prolonged organ storage: What temperature, how long, what time of day?
    Shaf Keshavjee, MD MSc FRCSC FACS
    Disclosure: Abbott: Advisory Board (Ongoing), Consultant (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); SQI Diagnostics: Consultant (Ongoing); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  4. Panel Discussion